Lung Cancer

Page 1 of 3 | Results 1 - 10 of 30

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi (BELLE-3)

Breast Cancer
Joseph Kash, MD

Naperville, Plainfield

Accepting Participants

A Randomized Phase II Study of Irinotecan and Cetuximab with or Without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-Type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy

Drugs used in chemotherapy, such as irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells...
Colorectal Cancer
Amaryllis Gil, MD

Elmhurst Hospital

Accepting Participants

A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer

Estrogen can cause the growth of breast cancer cells. Endocrine therapy using exemestane may fight breast cancer by lowering the amount of estrogen...
Breast Cancer
Amaryllis Gil, MD
Accepting Participants

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Brain and Neural
Oh-Hoon Kwon, MD

Naperville, Plainfield

Accepting Participants

CYBERKNIFE RSSearch Patient Registry - Long time study of Use of Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy (SRS/SBRT)

Central Nervous System, Neoplasms
Andy Su, MD

Elmhurst Hospital

Accepting Participants

CYBERKNIFE Registry for Prostate Cancer Radiosurgery - Multi-Institutional Registry for Prostate Cancer Radiosurgery (RPCR)

Prostate Cancer
Andy Su, MD

Elmhurst Hospital

Accepting Participants

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

Breast Cancer
Alexander Hantel, MD

Naperville, Plainfield

Accepting Participants

Connect MM - The Multiple Myeloma Disease Registry

Multiple Myeloma
Lucio DiNunno, MD
Accepting Participants

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants
Page 1 of 3 | Results 1 - 10 of 30